Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Obese women with PCOS are more likely to have fatty liver disease.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Minoxidil effectively treats female pattern hair loss.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

New drugs are improving treatment for hormone-related diseases in small pets.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.